Group A streptococcus
Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M
The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A.
Mesa Biotech Receives 510(k) Clearance, CLIA Waiver for Strep A Molecular Point-of-Care Test
The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs.
A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays
Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.
Strep A Sequences Point to Potential Scarlet Fever Culprit in the UK
Researchers identified Streptococcus pyogenes isolates from a lineage dubbed M1UK that are predicted to produce higher-than-usual levels of a scarlet fever-associated toxin.
The firm aims to stabilize and protect its existing molecular diagnostics business over the next 12 to 18 months, CEO Jack Kenny said.
Mar 21, 2019
GenePOC Strep A Test Granted FDA Clearance
Mar 14, 2019
Oct 25, 2018
Abbott Molecular Flu, Strep Tests Get FDA Clearance
Oct 5, 2017
Cepheid Xpress Strep A Test Clears FDA
Oct 25, 2016
FDA Clears Quidel Rapid MDx Strep Test
Jul 12, 2016
Oct 20, 2015